Dagenham, United Kingdom

Michael John Ashton


Average Co-Inventor Count = 8.0

ph-index = 3

Forward Citations = 56(Granted Patents)


Company Filing History:


Years Active: 1998-2001

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Michael John Ashton: Innovator in Pharmaceutical Compounds

Introduction

Michael John Ashton is a notable inventor based in Dagenham, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative compounds. With a total of 4 patents to his name, Ashton's work focuses on the pharmaceutical applications of phenyl compounds.

Latest Patents

Ashton's latest patents include groundbreaking inventions related to compounds containing phenyl linked to aryl or heteroaryl by an aliphatic or heteroatom-containing linking group. This invention is directed to the pharmaceutical use of these phenyl compounds for inhibiting tumor necrosis factor. Additionally, it encompasses the preparation of these compounds and the pharmaceutical compositions that contain them. Furthermore, the invention also addresses the pharmaceutical use of these compounds for inhibiting cyclic AMP phosphodiesterase.

Career Highlights

Throughout his career, Ashton has worked with prominent companies in the pharmaceutical industry, including Rhone Poulenc Rorer and Aventis Pharma Limited. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Ashton has collaborated with notable professionals in his field, including Garry Fenton and Andrew David Morley. These collaborations have likely enhanced his research and development efforts.

Conclusion

Michael John Ashton is a distinguished inventor whose work in pharmaceutical compounds has the potential to impact medical treatments significantly. His innovative patents and collaborations reflect his commitment to advancing the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…